GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » PB Ratio

OKUR (OnKure Therapeutics) PB Ratio : 0.51 (As of Apr. 04, 2025)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-04), OnKure Therapeutics's share price is $3.94. OnKure Therapeutics's Book Value per Share for the quarter that ended in Dec. 2024 was $7.78. Hence, OnKure Therapeutics's PB Ratio of today is 0.51.

The historical rank and industry rank for OnKure Therapeutics's PB Ratio or its related term are showing as below:

OKUR' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.53
Current: 0.5

During the past 3 years, OnKure Therapeutics's highest PB Ratio was 0.53. The lowest was 0.00. And the median was 0.00.

OKUR's PB Ratio is ranked better than
89.57% of 1285 companies
in the Biotechnology industry
Industry Median: 2.22 vs OKUR: 0.50

Back to Basics: PB Ratio


OnKure Therapeutics PB Ratio Historical Data

The historical data trend for OnKure Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics PB Ratio Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
PB Ratio
- - 1.11

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only - - - - 1.11

Competitive Comparison of OnKure Therapeutics's PB Ratio

For the Biotechnology subindustry, OnKure Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OnKure Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OnKure Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where OnKure Therapeutics's PB Ratio falls into.


;
;

OnKure Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

OnKure Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=3.94/7.779
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


OnKure Therapeutics  (NAS:OKUR) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


OnKure Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OnKure Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.